Elixxer Ltd. (ELIXF)
Sector: Drug Manufacturers - Specialty & Generic
Industry: Drug Manufacturers - Specialty & Generic
Elixxer Ltd.
OTC:ELIXFHealthcare · Drug Manufacturers - Specialty & Generic
CLOSED
Mkt Cap$3.19M
EV-
Float14.68M
O/S95.26M
VOL714 sh
Inst Own-
SI0.1%
Net Cash/Sh-
Dilution
MCap$3.19MFloat14.68MO/S95.26M
Dilution
Historical Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | 0.0001 | 0.0001 | 0.0000 | 0.0000 | 714 |
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
About
Elixxer Ltd. operates as an investment company specifically focused on the cannabis industry. This firm strategically deploys capital into fully licensed businesses engaged in the cultivation, production, and sale of medicinal and specialized cannabis, as well as cannabis-derived products, predominantly for the pharmaceutical sector.
Its investment reach extends across Canada, Australia, Italy, Jamaica, and Switzerland. Founded in 2004, the Montreal, Canada-based company adopted its current name, Elixxer Ltd., in August 2019, having previously been known as LGC Capital Ltd.
Key Metrics
Market Cap$3.19M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--
based on 95.26M shares outstanding
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ExchangeOTC
Country
CA
IPO Date-
Shares Outstanding95.26M
Authorized Shares
Float14.68M
52-Week Range
Volume
Average Daily Volume--
30d Avg
--
60d Avg
714
90d Avg
714
Earnings
Dividend History
No dividend history available